Prestige Consumer Healthcare (PBH) FY2026 results: revenue $1.1 billion, down 4.3% on the year
Prestige Consumer Healthcare Inc. (PBH) reported revenue of $1.1 billion for fiscal 2026, the year ended 31 March 2026, down 4.3% on the year before. Net income was $190 million, down 11.3%, and diluted earnings per share $3.91. The figures are the company's own, from the 10-K it filed with the SEC on 14 May 2026.
Revenue
$1.1 billion
-4.3% on the year
FY2019FY2026
Operating margin
28.4%
29.6% a year earlier
FY2019FY2026
Net income
$190 million
-11.3% on the year
FY2019FY2026
Diluted EPS
$3.91
-8.9% on the year
FY2019FY2026
this yearthe year beforeHover a bar for its figure.
The year in brief
What management said about the year
Guidance figures: 11 new.
Fourth-quarter revenue declined 5.0%: Revenue was $281.6 million, down 5.0% from $296.5 million, and down 6.4% excluding foreign currency. Management tied the drop to lower Eye & Ear Care sales and accelerated prior-year order timing.
Fiscal 2026 revenue down 4.3%: Full-year revenue was $1,088.7 million, down 4.3% from $1,137.8 million and down 4.5% excluding foreign currency. The company linked the decline to limited ability to supply Clear Eyes demand.
Clear Eyes supply still constraining sales: Management said it is prioritizing quality while increasing Clear Eyes output, and that limited supply held back Eye & Ear Care sales in the quarter.
Pillar5 facility costs excluded from adjusted: Fourth-quarter Pillar5 remediation, overhead and idle capacity costs were $8.4 million. Management said these costs are not indicative of the ongoing cost structure once the facility is fully remediated.
Free cash flow reached $246.4 million: Non-GAAP free cash flow was $246.4 million versus $243.3 million, from operating cash flow of $257.6 million and capital expenditure of $11.2 million.
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2026
FY2025
FY2024
On the year
Last 8 years
Operating cash flow
258
252
249
+2.4%
Capital expenditure
11.2
8.2
9.6
+35.9%
Free cash flow
246
243
239
+1.3%
Free cash flow margin
22.6%
21.4%
21.3%
Cash from investing
-137
-17.5
-20.1
Cash from financing
-156
-182
-241
Depreciation and amortisation
31.3
30.2
30.7
+3.6%
Share-based compensation
10.8
11.2
14.0
-2.9%
Buybacks
156
51.5
25.0
+203.4%
Diluted shares, weighted
49m
50m
50m
-2.7%
Balance sheet
$ million
FY2026
FY2025
FY2024
On the year
Last 8 years
Shareholders' equity
1,888
1,835
1,655
+2.9%
Debt
994
992
1,126
+0.2%
Operating lease liabilities
21.0
22.7
7.5
-7.8%
Finance lease liabilities
18.0
20.6
0.2
-12.9%
Other liabilities
574
532
530
+8.0%
Total liabilities and equity
3,494
3,402
3,318
+2.7%
Fixed assets
122
74.5
76.5
+63.2%
Goodwill
581
527
528
+10.2%
Intangible assets
2,300
2,295
2,321
+0.2%
Cash and equivalents
63.9
97.9
46.5
-34.8%
Receivables
192
194
177
-1.2%
Inventory
159
148
139
+7.7%
Other assets
77.0
65.0
31.6
+18.4%
Total assets
3,494
3,402
3,318
+2.7%
10-K for the year ended 31 March 2026, filed 14 May 2026: the filing.